These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 27566015

  • 1. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R, Chen KB, Xuan Y, Feng C, Xue M, Zeng YC.
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [Abstract] [Full Text] [Related]

  • 2. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z, Guo Y.
    Neoplasma; 2014 Sep; 61(4):476-80. PubMed ID: 25027744
    [Abstract] [Full Text] [Related]

  • 3. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR.
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [Abstract] [Full Text] [Related]

  • 4. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q, Fan J, Qian X, Lv Z, Zhang X, Han J, Wu F, Chen C, Du J, Guo M, Hu G, Jin Y.
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
    Wang X, Sun Q, Chen C, Yin R, Huang X, Wang X, Shi R, Xu L, Ren B.
    Oncotarget; 2016 Feb 16; 7(7):8029-42. PubMed ID: 26771237
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
    Zhang H, Duan CJ, Chen W, Wang SQ, Zhang SK, Dong S, Cheng YD, Zhang CF.
    Asian Pac J Cancer Prev; 2012 Feb 16; 13(5):2355-62. PubMed ID: 22901222
    [Abstract] [Full Text] [Related]

  • 9. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
    Ni SS, Zhang J, Zhao WL, Dong XC, Wang JL.
    Tumour Biol; 2013 Jun 16; 34(3):1813-8. PubMed ID: 23475633
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
    Pan YQ, Zhang X, Xu DP, Bao WG, Lin AF, Xu HH, Yan WH.
    Neoplasma; 2014 Jun 16; 61(4):468-75. PubMed ID: 24712846
    [Abstract] [Full Text] [Related]

  • 11. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX, Zhou RS, Xu HF, Wang JY, Yuan MH.
    Tumour Biol; 2013 Apr 16; 34(2):941-6. PubMed ID: 23264086
    [Abstract] [Full Text] [Related]

  • 12. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
    Chen P, Yu J, Knecht J, Chen Q.
    Cancer Epidemiol; 2013 Apr 16; 37(2):166-71. PubMed ID: 23312889
    [Abstract] [Full Text] [Related]

  • 13. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L, Yu L, Zhu B, Wu S, Song W, Gong X, Wang D.
    BMC Cancer; 2016 Nov 10; 16(1):876. PubMed ID: 27832750
    [Abstract] [Full Text] [Related]

  • 14. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
    Wang JL, Wu DW, Cheng ZZ, Han WZ, Xu SW, Sun NN.
    Asian Pac J Cancer Prev; 2014 Nov 10; 15(12):4865-9. PubMed ID: 24998555
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
    Han KY, Gu X, Wang HR, Liu D, Lv FZ, Li JN.
    Tumour Biol; 2013 Apr 10; 34(2):821-5. PubMed ID: 23229099
    [Abstract] [Full Text] [Related]

  • 16. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K.
    Ann Surg Oncol; 2013 Dec 10; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [Abstract] [Full Text] [Related]

  • 17. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y, Tian H, Chen P, Lin Q.
    Oncotarget; 2017 Apr 04; 8(14):22730-22740. PubMed ID: 28186994
    [Abstract] [Full Text] [Related]

  • 18. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
    Xu Y, Chen Z, Zhang G, Xi Y, Sun R, Wang X, Wang W, Chai F, Li X.
    Tumour Biol; 2016 Oct 04; 37(10):14321-14328. PubMed ID: 27599983
    [Abstract] [Full Text] [Related]

  • 19. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan 04; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

  • 20. Analysis of MAT3 gene expression in NSCLC.
    Zheng S, Du Y, Chu H, Chen X, Li P, Wang Y, Ma Y, Wang H, Zang W, Zhang G, Zhao G.
    Diagn Pathol; 2013 Oct 09; 8():166. PubMed ID: 24107548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.